Medical News

RSS

Provectus Pharmaceuticals commences Phase 1 study of PV-10 for liver cancer

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 1 study of PV-10 for liver cancer. The study will enroll up to six subjects with cancer metastatic to the liver or with recurrent liver cancer. PV-10 is the company’s lead oncology drug candidate that is also currently undergoing Phase 2 study for metastatic melanoma.

1 Oct 2009

FDA updates consumers on food and medical safety

The U.S. Food and Drug Administration has posted on its Web site several Consumer Update videos.

1 Oct 2009

Adimab announces the completion of Series D financing

Adimab, Inc., a world leader in human antibody discovery, today announced the closing of a Series D financing led by Google Ventures with participation by previous investors Polaris Ventures, SV Life Sciences, OrbiMed Advisors and Borealis Ventures. Bill Maris of Google Ventures will join Adimab's Board of Directors. The total amount of the financing was not disclosed.

1 Oct 2009

Contact Solutions announces its continued commitment to lower health care costs

Contact Solutions, a leading provider of on-demand contact automation solutions including IVR, email/text messaging and web transactions for business and government, announces today their continued commitment to lowering health care costs.

1 Oct 2009

Jim Mark has been appointed as new Vice President of Private Care Association of Florida

The Private Care Association of Florida has elected Jim Mark of American Home Companions as Vice President of the association. Mr. Mark is attending the national Private Care Association Conference in Washington D.C. this week in an effort to bring attention to the critical issues facing private care options.

1 Oct 2009

Public lecture to highlight what causes cell division to go wrong and lead to cancer

University of Leicester research which substantially increases our understanding of what causes cell division to go wrong and lead to cancer will be highlighted in a public lecture at the University on Wednesday 14th October at 5.30-6.30pm.

1 Oct 2009

Studies show vitamin D plays an important role in preventing respiratory infections

Several studies and articles published this year show that vitamin D plays an important role in the prevention of respiratory infections such as the cold and flu.

1 Oct 2009

Cutting Edge Information hopes to see ill patients have speedier access to potential cures

The FDA has approved the first set of vaccines aimed at preventing H1N1 infection after an approval process of less than four months. Cutting Edge Information is currently analyzing the lessons learned that may emerge for both the Food and Drug Administration (FDA) and life science firms after this crisis experience.

1 Oct 2009

TMS closes final tranche of Series E Preferred Financing to a total of $6 million

TechniScan Medical Systems (TMS) Inc., a Salt Lake City-based developer of ultrasound technology for breast imaging, announced the close of the final tranche of their Series E Preferred Financing of $1.1 million, bringing the total raised in the Series E financing to just over $6 million.

1 Oct 2009

Raptor Pharmaceutical appoints Llew Keltner to its board of directors

Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors.

1 Oct 2009

Cardinal Health Foundation awards more than $1 million fund to improve the quality of care

The Cardinal Health Foundation today announced it will award more than $1 million in funding to help U.S. hospitals, health systems and community health clinics improve the efficiency and quality of care.

1 Oct 2009

CCF to continue its million dollar ad campaign against NYC's PSA campaign

Today, the Center for Consumer Freedom (CCF) is running a full-page ad in the New York Times, continuing its million dollar ad campaign against the New York City Department of Health's hyperbolic "Don't drink yourself fat" PSA campaign. The Center will also continue to run ads in the New York Daily News and New York Post that ask New Yorkers, "What's Next?" and "Big Apple or Big Brother?"

1 Oct 2009

Treating mothers for mild gestational diabetes reduces infant deaths and birth-related complications

Treating pregnant women for mild gestational diabetes resulted in fewer cesarean sections and other serious birthing problems associated with larger than average babies, according to a study conducted in part at the University of North Carolina at Chapel Hill.

1 Oct 2009

Cord Blood America to open cryogenic research and storage laboratory in Las Vegas

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it is opening its new Corporate headquarters and cryogenic research and storage laboratory in Las Vegas, as planned, the first week of October.

1 Oct 2009

Children and adolescents over five are at risk from malaria

Insecticide treated mosquito nets reduce the chances of developing life-threatening malaria in Africa, however recent research shows that older children are the least well protected by nets in the community. The research, published in the open access journal BMC Public Health, has found that parents and their young children were much more likely to have malaria nets than older children.

1 Oct 2009

Watch4net installs its APG Software Suite at Clarian Health

Current economic conditions are affecting healthcare providers in terms of limited personnel and budget constraints," said Bob Swann, Executive Director, IT Operations, Clarian Health. An industry typically marked by growth is starting to feel the effects of the economic slowdown. Senior level executives are being tasked to run leaner organizations with fewer resources and still maintain a premier level of patient care.

1 Oct 2009

USPTO allows BioMarin's claims covering the approved administration of sapropterin dihydrochloride with food

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent and Trademark Office has allowed claims covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food, based on the discovery that food increases the bioavailability of Kuvan. The company expects that the patent, which expires in 2024, will officially issue later this year.

1 Oct 2009

Stem cell therapy aims to prevent permanent damage from heart attacks

All patients arriving at UCSF's Emergency Department with heart attack will continue to be treated with standard measures. Patients who meet the medical criteria for the trial will be able to elect to receive the stem cell therapy within seven days after their heart attack.

1 Oct 2009

Revolutions Medical's new corporate headquarters in Charleston

Revolutions Medical Corporation ("RevMed" or the "Company") (OTCBB: RMCP), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that it has moved its expanded operations to new corporate headquarters in Charleston and is hosting a Grand Opening ceremony on October 8th, 2009 at 5:30pm - 7:30pm ET

1 Oct 2009

CHCC announces the filing of SEC Form 15

China Health Care Corporation announced that the Company filed a Form 15 as notice of suspension of the duty to file periodic reports under Sections 13 and 15(d) of the Securities Exchange Act of 1934 with the Securities and Exchange Commission ("SEC") on September 29, 2009. The Company is, thereby, voluntarily suspending its reporting obligations under the Securities Exchange Act of 1934.

1 Oct 2009

Medical News

Provectus Pharmaceuticals commences Phase 1 study of PV-10 for liver cancer

FDA updates consumers on food and medical safety

Adimab announces the completion of Series D financing

Contact Solutions announces its continued commitment to lower health care costs

Jim Mark has been appointed as new Vice President of Private Care Association of Florida

Public lecture to highlight what causes cell division to go wrong and lead to cancer

Studies show vitamin D plays an important role in preventing respiratory infections

Cutting Edge Information hopes to see ill patients have speedier access to potential cures

TMS closes final tranche of Series E Preferred Financing to a total of $6 million

Raptor Pharmaceutical appoints Llew Keltner to its board of directors

Cardinal Health Foundation awards more than $1 million fund to improve the quality of care

CCF to continue its million dollar ad campaign against NYC's PSA campaign

Treating mothers for mild gestational diabetes reduces infant deaths and birth-related complications

Cord Blood America to open cryogenic research and storage laboratory in Las Vegas

Children and adolescents over five are at risk from malaria

Watch4net installs its APG Software Suite at Clarian Health

USPTO allows BioMarin's claims covering the approved administration of sapropterin dihydrochloride with food

Stem cell therapy aims to prevent permanent damage from heart attacks

Revolutions Medical's new corporate headquarters in Charleston

CHCC announces the filing of SEC Form 15

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News